Navigation Links
Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
Date:1/6/2009

ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational. The contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is part of NIAID's clinical resource infrastructure to accelerate Phase 1 studies of promising clinical stage drugs or vaccines that address emerging and re-emerging infectious tropical diseases and bioweapon pathogens. The Phase 1B clinical study of SQ109 should be initiated in Q1 2009.

SQ-109 is a new diamine antibiotic intended to replace one or more of the current first-line anti-TB drugs and simplify patient therapy. SQ109 was granted U.S. FDA Fast Track designation and FDA/EMEA Orphan Drug Designation in 2007. SQ109 shows activity against drug sensitive and multi-drug resistant (MDR and XDR) Mycobacterium tuberculosis, the causative agent of TB. The Phase 1B study will assess safety and pharmacokinetics of multiple doses of SQ109 in healthy subjects.

"This is absolutely the best of both worlds for Sequella," commented Dr. Carol Nacy, Sequella CEO. "We again successfully competed for support from our most valued funding partner, NIAID, while retaining the capacity to work with the same industry-leading contract research organization, Quintiles Transnational, that conducted our first-in-human Phase 1A trial for SQ109.

The trial will be conducted at the Overland Park Quintiles Transnational Phase 1 facility in Lenexa, Kansas.

About Sequella

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for diseases of epidemic pot
'/>"/>

SOURCE Sequella, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
2. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
3. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
4. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
5. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
6. Novel Compound Shows Promise for Treatment of Alcoholism
7. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
8. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
9. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
10. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
11. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 Medical devices are any ... biological product. In light of their different mechanisms, actions ... much more complicated than drug trails due to their ... safety instead of evaluating both safety and efficacy (which ... (which is the same as the SFDA) evaluate MDs ...
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- United Medical Education, a ... Support (ACLS), Pediatric Advanced Life Support (PALS) and Basic ... and ACLS online course manuals. In order ... need to build an account with the company. By ... programs, United Medical Education is setting a precedent among ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... 1 Varian, Inc.,(NasdaqGS: VARI) announced today ... NDLipids is a simple to use, non-drip ... from biofluids., It is intended for ... and,life science industries performing quantitative and qualitative ...
... Biosensors,International Group, Ltd ("Biosensors", "Company"), (Bloomberg: ... stent,developed by Biosensors, has demonstrated equal safety ... industry leading drug-eluting stent, CYPHER,SELECT(TM) ("Cypher"), based ... results of the landmark study were presented ...
Cached Medicine Technology:96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 3
(Date:5/18/2013)... 2013) A ground-breaking advance in colonoscopy technology ... research presented today at Digestive Disease Week (DDW). ... time for colonoscopies and exploring safer methods for ... use a device called a colonoscope to examine ... allows a doctor to look for precancerous polyps ...
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... 18, 2013 During Better Hearing and ... consider the legal protections they have, including the right ... with their child’s treatment or hearing aid device, attorney ... the American Speech-Language-Hearing Association has used the month of ... promote treatment, such as cochlear implants, which can improve ...
(Date:5/18/2013)... 2013 Adolescents, especially young males, who ... or “K2” are landing in emergency rooms across America. ... drug epidemic with a new treatment program for ... to research from the National Institute on Drug Abuse, ... among American teenagers. In 2012, 11 percent of high ...
(Date:5/18/2013)... Rolling Meadows, IL (PRWEB) May 18, 2013 ... urges Oregon Gov. John A. Kitzhaber, M.D., (D) ... existing state law by prohibiting minors under the age ... signature, Oregon would become the third state in the ... Vermont already have enacted similar indoor tanning bans for ...
Breaking Medicine News(10 mins):Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2
... way to spot hearing problems, study finds, , , TUESDAY, Feb. 19 ... to the soul, they may also provide a clear view to ... that the eyes can provide clues that tell researchers how well ... diagnosing hearing problems in babies, very young children and in people ...
... Built near Current Hospital, WALLA WALLA, Wash., ... B. Peake announced today the Department of,Veterans Affairs ... on mental health at the Walla Walla VA,Medical ... provide for the health care,needs of Washington,s veterans ...
... of the virus that caused severe acute respiratory syndrome (SARS) ... the virus infecting humans originated in bats. , The analysis ... assertions that SARS was eradicated in 2004 when thousands of ... source and killed in an effort to eliminate the risk ...
... 19 U.S. Marine Corps Casualty Assistance,Calls Officers ... Marine,s family,concerning the loss, injury or illness of ... to execute this critical duty by noted author ... with TriWest Healthcare Alliance, Steen presented,her Grief Solutions ...
... more likely to suffer from postpartum depression than their ... , In the study of 4,332 new mothers from ... 40 percent of Iowa mothers with a household income ... In contrast, only 13 percent of new mothers with ...
... show patients live average of 4 years longer than those ... The lack of a chromosome actually helps people with a ... new findings show. , Gliomatosis cerebri is a type of ... an extremely variable prognosis. A study of 25 people with ...
Cached Medicine News:Health News:Eyes a Window to Hearing Loss? 2Health News:Eyes a Window to Hearing Loss? 3Health News:Evolutionary history of SARS supports bats as virus source 2Health News:Evolutionary history of SARS supports bats as virus source 3Health News:Evolutionary history of SARS supports bats as virus source 4Health News:Joanne Steen Presents Grief Solutions at the Headquarters Marine Corps 2008 Casualty Conference 2Health News:Study: low-income women more likely to suffer from postpartum depression 2Health News:Study: low-income women more likely to suffer from postpartum depression 3Health News:Missing Chromosome Improves Response to Brain Tumor Treatment 2
Colibri style tips. Double toothed tips with 0.10 mm teeth spaced 1 mm apart and 7 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in the closed position. Polished finish. Tips: 0.12 mm teeth....
Straight shafts with 1 x 2 teeth. Wide serrated handle with polished finish....
Smooth 90 degree jaws with locking screw maintain proper stretch of sleeve for securing silicone bands....
Medicine Products: